AskBio Announces Gustavo Pesquin as New CEO

Research Triangle Park, NC, March 9, 2023 (PRNewswire) -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today announced that Gustavo Pesquin will become the company's next Chief Executive Officer (CEO) as of March 11, 2023. Pesquin joins AskBio from Amneal Pharmaceuticals, Inc., where he served as Chief Commercial Officer.

Read article here.